Phase 1 study for people with Rheumatoid Arthritis

Recruiting Phase 1

Sources: ClinicalTrials.gov Checked: 11 October 2026 Not medical advice

This trial at a glance

Status Recruiting
Phase Phase 1
Sponsor Kali Therapeutics, Inc.
Registry number NCT07234773
Started 6 March 2026 Today 16 October 2026 Estimated completion 1 February 2027

Where this trial is running

Trial sites and the status recorded for each
SiteCityState or countryStatus at this site
Kali Study Site Bayswater Australia Recruiting

voxsanity.com.au · trial sites from public registries · registry record synced 11 October 2026 · not medical advice

Who can join

Age 18 Years to 75 Years
Sex Anyone, regardless of sex
Healthy volunteers Not accepted
Enrolment target 24

The official eligibility criteria

Registry text, reproduced exactly. These are the words the trial's sponsor published on ClinicalTrials.gov. They have not been edited, shortened or rewritten, and they are written for researchers rather than for patients.

Inclusion Criteria:

1. 18 to 75 years old

2. Diagnosis of adult-onset RA for at least 6 months

3. Moderately to severely active RA

4. Inadequate treatment response as defined in the protocol

5. RF + or ACPA+

6. Stable use of traditional DMARDs is permitted

7. Willing and able to comply with all study assessments and adhere to the protocol schedule and restrictions.

Exclusion Criteria:

1. Functional class IV as defined by the ACR Classification of Functional Status in RA

2. Presence of any concomitant autoimmune disease other than RA

3. Active infection, history of serious recurrent or chronic infection

4. History of progressive multifocal leukoencephalopathy

5. Have a diagnosis or history of malignant disease within 5 years or breast cancer diagnosed within the previous 10 years.

6. History of or planned organ transplant and/or autologous or allogeneic hematopoietic stem cell transplantation

7. Receipt of live vaccine within 4 weeks

8. Major surgery (including joint surgery) within 8 weeks prior to screening or planned major surgery within 6 months after study

9. Women who are pregnant or breastfeeding

10. Significant or uncontrolled medical disease that would preclude participant participation

Dates on the record

Started 6 March 2026
Estimated completion 1 February 2027
Registry last updated 10 March 2026
Checked by Voxsanity 11 October 2026

Results, publications and the official record

Sources and dates

  • ClinicalTrials.gov – the record this page reformats
  • ClinicalTrials.gov processing date: 10 March 2026.
  • This page last checked by Voxsanity: 11 October 2026.

Voxsanity reformats data from public registries into this layout. It does not edit, interpret or add to what the registry published.

Not medical advice.

Individual trial records are refreshed on a rolling basis rather than all at once, so a record may be up to several weeks old. Each trial page and trial card shows the date its own record was last synced. Where a record has lagged, its status, sites and enrolment can differ from the current registry state in either direction, so check the registry link on the trial page before acting on them.

Letter for your doctor

A one-page summary of this trial to print or email to your GP. It carries the registry's own record of the trial and its eligibility criteria, and nothing Voxsanity has written about whether it suits you.